Latest filing published 24 Mar 2022 for Oasmia Pharmaceutical AB, €19k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter Zonabend: trading record in brief
Filings by Peter Zonabend span 2 companies, the busiest being Oasmia Pharmaceutical AB and Vivesto AB. Between 5 July 2019 and 22 January 2026, the trades on record add up to 7 filings.
The open-market record is one-sided, with 3 purchases worth €114k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
The median purchase comes to €30k.
On 27 January 2026 came the latest disclosure, an open-market purchase for €8,703 in Vivesto AB. The median gap between a trade and its publication by Finansinspektionen is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Zonabend
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 120,000 shares@ SEK 1.680.3% of flowBTA (betald tecknad aktie)ISIN SE0017564958FI:csv-416e0406ea0a0460f305
- 100,000 shares@ SEK 3.02620.4% of flowAktieISIN SE0000722365FI:csv-67f71bc251641b0f1c2bCanonical exit: 14 Oct 2021 (T+90)
- 500,000 shares@ SEK 2.001.3% of flowBTA (betald tecknad aktie)ISIN SE0013460557FI:csv-156be50c6b5c4c39502b
- 625,000 shares@ SEK 1.291.0% of flowTeckningsrättISIN SE0013460540FI:csv-5b6f892dad45aa93e31cCanonical exit: 23 Feb 2020 (T+90)
- 24,193,548 shares@ SEK 3.1097.7% of flowAktieISIN SE0000722365FI:csv-c7350686ad825c8fbba2
5 of 5 declarations